Clinical trial
Adoptive Cellular Immunotherapy Following Autologous Peripheral Blood Stem Cell…
NCT00439465 · Dartmouth-Hitchcock Medical Center, Other · Completed
Key facts
| NCT number | NCT00439465 |
|---|---|
| Title | Adoptive Cellular Immunotherapy Following Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma |
| Official title | Adoptive Cellular Immunotherapy Following Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma |
| Lead sponsor | Dartmouth-Hitchcock Medical Center, Other |
| Collaborators | The Leukemia and Lymphoma Society |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Myeloma, Transplant-eligible Patients |
| Intervention type | Biological |
| Interventions | Ex-vivo expanded effector cells |
| Enrollment | 23 |
| Start date | Jan 1, 2007 |
| Primary completion | Oct 15, 2012 |
| Completion | Nov 30, 2012 |
| First posted | Feb 23, 2007 |
| Last update posted | Mar 26, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: